samedan logo

 
 
spacer
home > white papers > Outsourcing and Insourcing: How Eurofins solves the bio/pharma industry’s challenges associated with meeting drug development timelines and budgets with restricted headcounts - Eurofins BioPharma Product Testing
WHITE PAPERS
logo_Eurofins.jpg

Eurofins BioPharma Product Testing

phone +32 2 766 16 20
email info@eurofins.com
web http://www.eurofins.com
email 48 Avenue Herrmann-Debroux B-1160 Brussels Belgium

Outsourcing and Insourcing: How Eurofins solves the bio/pharma industry’s challenges associated with meeting drug development timelines and budgets with restricted headcounts


Outsourcing and Insourcing: How Eurofins solves the bio/pharma industry’s challenges associated with meeting drug development timelines and budgets with restricted headcounts
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

‘Privates Leading the Disruption in Healthcare’ Conference

NEW YORK, NY – APRIL 7, 2022 – David MacMurchy, CEO and Robert Jones, Chief Financial Officer, Lightship, are providing key insights into how precision medicine is changing the landscape of clinical trial development at Goldman Sach’s invitation only event “The New Guard: Privates Leading the Disruption in Healthcare” on April 7th. Lightship is a global virtual-first and hybrid clinical research services provider.
More info >>


White Papers

Technology Solutions - Driving efficiencies, quality and operational excellence

Worldwide Clinical Trials Ltd

Clinical trials involve the entry, analysis and reporting of millions of pieces of data; year-on-year, the amount of data required to manage efficacy and safety increases exponentially. Recently, solutions available to support this activity have grown in numbers and complexity. The rise of Tablets and Smart Phones combined with the growth of Cloud or SAS solutions has resulted in the technology landscape required to support complex, global studies becoming more confusing.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement